News
We've discovered 2 warning signs about Eli Lilly. View them for free. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 26%. Looking ahead, revenue is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results